Concepedia

Paul Stoffels

PS

Statistics

Publications

11

Citations

1.6K

H-Index

11

Active since

1991

Affiliations

Janssen (Belgium)(Current)

Goethe University Frankfurt

Office of the Director

Johnson & Johnson (United States)

Paul Stoffels is an author at Janssen (Belgium) specializing in infectious diseases, pharmacology, and antiretroviral therapy.

Publications per year

1991–2023

11

Publications

11

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

Noe B. Mercado, Roland Zahn, Frank Wegmann et al. · Nature · 2020 · 906 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +11

Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.

Rudi Pauwels, Koen Andries, Zeger Debyser et al. · Proceedings of the National Academy of Sciences · 1993 · 190 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)

Francis S. Collins, Paul Stoffels · JAMA · 2020 · 129 citations

Veterinary Medicine, Immunology, Infectious Diseases +13

Virological and immunological analysis of a triple combination pilot study with loviride, lamivudine and zidovudine in HIV-1-infected patients

Schlomo Staszewski, Veronica Miller, S. Rehmet et al. · AIDS · 1996 · 93 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

New Vaccines against Epidemic Infectious Diseases

John-Arne Røttingen, Dimitrios Gouglas, Mark B. Feinberg et al. · New England Journal of Medicine · 2017 · 85 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +14

1–5 of 11